Cargando…

Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia

INTRODUCTION: Metabolic disturbances are common in patients maintained on neuroleptics. These abnormalities significantly increase the physical comorbidity and mortality rates due to cardiovascular disease. We hypothesized that 5-HT receptor genes polymorphisms have associations with drug-induced me...

Descripción completa

Detalles Bibliográficos
Autores principales: Paderina, D., Pozhidaev, I., Bocharova, A., Kornetova, E., Boiko, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475604/
http://dx.doi.org/10.1192/j.eurpsy.2021.1027
_version_ 1784789945355862016
author Paderina, D.
Pozhidaev, I.
Bocharova, A.
Kornetova, E.
Boiko, A.
author_facet Paderina, D.
Pozhidaev, I.
Bocharova, A.
Kornetova, E.
Boiko, A.
author_sort Paderina, D.
collection PubMed
description INTRODUCTION: Metabolic disturbances are common in patients maintained on neuroleptics. These abnormalities significantly increase the physical comorbidity and mortality rates due to cardiovascular disease. We hypothesized that 5-HT receptor genes polymorphisms have associations with drug-induced metabolic syndrome development in schizophrenic patients. OBJECTIVES: To investigate the role of polymorphic variants of serotonin receptors genes in the development of antipsychotic-induced metabolic syndrome. METHODS: 467 patients with schizophrenia receiving long-term antipsychotic therapy were investigated. The mean age was 40.0±11.6 years. The standard phenol-chloroform method for DNA isolation was used. Genotyping was carried out on eight SNP’s of genes HTR1A, HTR2A, HTR3A and HTR2C with the MassARRAY(®) Analyzer 4 (Agena Bioscience™) using the set SEQUENOM Consumables iPLEX Gold 96 on the base The Core Facility “Medical Genomics”, Tomsk NRMC. RESULTS: The prevalence of metabolic syndrome was 26.1%. In the study sample, there were significantly more women with metabolic syndrome (56.6%) than men (43.4%) (p=0.002). The majority of patients with metabolic disturbances were aged >40 years (62.3%), versus 40.9% in the group without metabolic disorders (p<0.001). The duration of the disease was statistically significantly higher in the group of patients with metabolic syndrome (p=0.003). We did not find statistically significant associations of polymorphic variants of the studied genes with the development of the drug-induced metabolic syndrome. CONCLUSIONS: Our results do not demonstrate any significant association between allelic variants of serotonin receptor genes and metabolic syndrome in patients with schizophrenia. Conflict of interest. The authors declare no conflict of interest. Supported by Grant of RSF 19-75-10012.
format Online
Article
Text
id pubmed-9475604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94756042022-09-29 Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia Paderina, D. Pozhidaev, I. Bocharova, A. Kornetova, E. Boiko, A. Eur Psychiatry Abstract INTRODUCTION: Metabolic disturbances are common in patients maintained on neuroleptics. These abnormalities significantly increase the physical comorbidity and mortality rates due to cardiovascular disease. We hypothesized that 5-HT receptor genes polymorphisms have associations with drug-induced metabolic syndrome development in schizophrenic patients. OBJECTIVES: To investigate the role of polymorphic variants of serotonin receptors genes in the development of antipsychotic-induced metabolic syndrome. METHODS: 467 patients with schizophrenia receiving long-term antipsychotic therapy were investigated. The mean age was 40.0±11.6 years. The standard phenol-chloroform method for DNA isolation was used. Genotyping was carried out on eight SNP’s of genes HTR1A, HTR2A, HTR3A and HTR2C with the MassARRAY(®) Analyzer 4 (Agena Bioscience™) using the set SEQUENOM Consumables iPLEX Gold 96 on the base The Core Facility “Medical Genomics”, Tomsk NRMC. RESULTS: The prevalence of metabolic syndrome was 26.1%. In the study sample, there were significantly more women with metabolic syndrome (56.6%) than men (43.4%) (p=0.002). The majority of patients with metabolic disturbances were aged >40 years (62.3%), versus 40.9% in the group without metabolic disorders (p<0.001). The duration of the disease was statistically significantly higher in the group of patients with metabolic syndrome (p=0.003). We did not find statistically significant associations of polymorphic variants of the studied genes with the development of the drug-induced metabolic syndrome. CONCLUSIONS: Our results do not demonstrate any significant association between allelic variants of serotonin receptor genes and metabolic syndrome in patients with schizophrenia. Conflict of interest. The authors declare no conflict of interest. Supported by Grant of RSF 19-75-10012. Cambridge University Press 2021-08-13 /pmc/articles/PMC9475604/ http://dx.doi.org/10.1192/j.eurpsy.2021.1027 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Paderina, D.
Pozhidaev, I.
Bocharova, A.
Kornetova, E.
Boiko, A.
Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
title Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
title_full Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
title_fullStr Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
title_full_unstemmed Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
title_short Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
title_sort drug-induced metabolic syndrome hasn’t associations with 5-ht receptor genes polymorphisms in patients with schizophrenia
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475604/
http://dx.doi.org/10.1192/j.eurpsy.2021.1027
work_keys_str_mv AT paderinad druginducedmetabolicsyndromehasntassociationswith5htreceptorgenespolymorphismsinpatientswithschizophrenia
AT pozhidaevi druginducedmetabolicsyndromehasntassociationswith5htreceptorgenespolymorphismsinpatientswithschizophrenia
AT bocharovaa druginducedmetabolicsyndromehasntassociationswith5htreceptorgenespolymorphismsinpatientswithschizophrenia
AT kornetovae druginducedmetabolicsyndromehasntassociationswith5htreceptorgenespolymorphismsinpatientswithschizophrenia
AT boikoa druginducedmetabolicsyndromehasntassociationswith5htreceptorgenespolymorphismsinpatientswithschizophrenia